The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, producing billions in revenue , its patent expiration created a wave of generic competition , significantly diminishing its dominance. While some firms may try to capitalize on similar conditions , the existing landscape d